Announcement

Advancing Technology Innovation in Clinical Research

Beaufort provides Medrio with expertise and advisory support on launch of newly launched AI-enabled reporting tool

At Beaufort, we continuously explore cutting-edge technologies and integrated CRO solutions to better serve the evolving needs of our clients. As part of this commitment, Bill Trembley, our Senior Vice President and Chief Technology Officer, was invited to serve on Medrio’s Early Adopter Program advisory committee, where he was instrumental in assessing and shaping their newly launched AI-enabled reporting capabilities. 

Bill’s contributions on this project reflect his dedication to leveraging technology to help in vitro diagnostic (IVD) and medical device sponsors achieve their research goals with greater efficiency and confidence. This advanced tool from Medrio, one of our primary EDC providers, enables study teams to quickly extract meaningful insights from complex datasets, significantly improving the speed and accuracy of trend identification and progress tracking.

See an excerpt of the press release below to learn more—or please feel free to reach out via email to [email protected] if you have any questions or wish to discuss.


Medrio’s Launches AI-Enabled Reporting, Tackling Increasing Data Challenges in Clinical Trials

SAN FRANCISCO, CA – January 29, 2025—Medrio, a global leader in clinical trial technology, today announced the release of AI-enabled reporting, an innovative new capability available within Medrio CDMS/EDC. Medrio’s AI-enabled reporting will simplify data exploration with machine learning and natural language prompts, enabling faster data visualizations and insight discovery.

“Our AI-enabled reporting alleviates the pressures on study teams to manage vast amounts of clinical trial data,” said Mike Stocks, Chief Technology Officer at Medrio. “By overhauling our reporting capabilities and embedding machine learning into our CDMS/EDC platform, we are equipping study teams with the tools to extract meaningful insights quickly. As a result, trials can move forward without unnecessary and often costly delays.”

Clinical trials are generating more data than ever before, increasing the time and costs required for data cleaning and analysis. With the daily costs of clinical trials running into the tens of thousands, delays can quickly strain budgets and extend timelines. As data demands grow, the industry faces mounting pressure to balance efficiency with maintaining data integrity and regulatory standards.

“Each clinical study brings with it its own challenges, both in operations and data management,” said Bill Trembley, Senior Vice President and Chief Technology Officer at Beaufort, a MedTech-focused contract research organization.  “The sheer volume and complexity of study data warrants the need for robust tools to ensure goals around safety, integrity, and efficiency continue to be met. These significant enhancements have the potential to dramatically improve how quickly we can identify trends and track progress, allowing us to provide our clients with more timely and actionable insights.”

Six industry-leading sponsors and CROs in Medrio’s Early Adopter Program are guiding the development of its AI-enabled reporting. Program members, including Beaufort…

Click here to read full press release

View all news & insights